Sitemap

• HOME
  • Sitemap
  • Legal notice
  • Contact us
• ABOUT US
  • Strategy
  • Board of Directors
  • Management team
  • Collaborations
• RESEARCH AND DEVELOPMENT
  • Development pipeline
  • Central nervous system disorders
    • Nalmefene
    • PDE10
  • Inflammation
    • ELB353
    • VAP-1
    • VAP-1 Antibody
  • Pre-clinical research
• INVESTORS
  • Share monitor
  • Stock exchange releases
    • Stock exchange releases archive
    • Join mailing list
  • Share information
    • Major shareholders
    • Ownership structure
    • Price history search
    • Changes in holdings
    • Changes in numbers of shares and share capital
    • Option programs
    • Authorisations
    • Analyst coverage
  • Financial information
    • Interim reports 2005 - 2009
    • Annual reports 2005 - 2009
    • Key figures
    • Formulas for the calculation of the key figures
    • Adoption of IFRS standards
  • Governance
    • Corporate governance
    • Public insiders
    • Shareholders´ meeting
      • Shareholders´ meeting 2008
      • Previous shareholders´ meeting
    • Auditors
    • Articles of association
    • Compensation
    • Risk management
  • Presentations
• MEDIA
  • Press releases
  • Press image gallery